In our study, mortality was higher in patients with high cTnI levels (HR 3.61 [CI 95%, 0.70,1.86], p<.001), patients suffering from both hypertension and diabetes together (HR 4.14 [CI 95%, 0.88,1.96], p<.001), and in patients who had a history of ischemic heart disease (IHD) (HR 1.85 [CI 95%, 0.18,1.05], p=.005). This evidence concerns the gene TNNI3 and coronary artery disorder.